MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
-0.96%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$89.2M
AUM Growth
+$89.2M
(-18%)
Cap. Flow
+$4.15M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
96.53%
Holding
13
New
–
Increased
1
Reduced
3
Closed
–
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$7.9M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$1.46M |
| 2 |
TG Therapeutics
TGTX
|
$1.37M |
| 3 |
Atara Biotherapeutics
ATRA
|
$935K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $26.9M | 30.17% | 8,282,204 +2,432,204 | +42% | +$7.9M |
|
2
Invivyd
IVVD
$204M
| $21M | 23.53% | 6,398,250 | – | – |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $9.85M | 11.04% | 715,880 | – | – |
|
4
Stoke Therapeutics
STOK
$1.08B
| $6.96M | 7.81% | 527,150 | – | – |
|
5
BridgeBio Pharma
BBIO
$9.89B
| $4.23M | 4.75% | 466,200 | – | – |
|
6
Curis
CRIS
$20.9M
| $4.18M | 4.68% | 4,243,293 | – | – |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.11M | 4.61% | 61,200 -21,700 | -26% | -$1.46M |
|
|
8
TG Therapeutics
TGTX
$4.65B
| $3.09M | 3.46% | 726,200 -321,700 | -31% | -$1.37M |
|
9
Leap Therapeutics
LPTX
$12M
| $3.06M | 3.43% | 2,664,400 | – | – |
|
|
VERV
10
DELISTED
Verve Therapeutics
VERV
| $2.73M | 3.06% | 178,500 | – | – |
|
|
11
Atara Biotherapeutics
ATRA
$84.6M
| $2.1M | 2.35% | 269,253 -120,100 | -31% | -$935K |
|
12
ProQR Therapeutics
PRQR
$237M
| $779K | 0.87% | 1,001,800 | – | – |
|
|
NEXI
13
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $215K | 0.24% | 133,442 | – | – |
|